GENERAC HOLDINGS INC.·4

Jul 7, 6:16 PM ET

Taffe Norman P 4

4 · GENERAC HOLDINGS INC. · Filed Jul 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Generac (GNRC) President Norman Taffe Sells Shares, Exercises Options

What Happened

  • Norman P. Taffe, President of Generac Home, exercised stock options and sold company shares on 2026-07-06. He exercised 250 shares at a strike price of $119.54 (cost ≈ $29,885) and sold 550 shares in open-market transactions at $256.00 per share, generating proceeds of $140,800. The filing also shows two derivative-related dispositions at $0.00 (150 and 100 shares) reported the same day.

Key Details

  • Transaction date: 2026-07-06 (filed 2026-07-07 — timely)
  • Exercises (code M, acquired): 150 shares @ $119.54 ($17,931) and 100 shares @ $119.54 ($11,954) — total cost ≈ $29,885
  • Open-market sales (code S, disposed): 200, 100, 150, and 100 share lots at $256.00 each — total sold = 550 shares; proceeds = $140,800
  • Two derivative dispositions reported at $0.00 (150 & 100 shares) — $0 proceeds
  • Shares owned after transaction: Not specified in the filing
  • Footnotes: F1 — 10b5-1 trading plan adopted 03-06-2026; F2 — multiple lots combined; F3 — grants have graded vesting schedules

Context

  • The filing shows option exercises followed by open-market sales. Exercising options at $119.54 then selling at $256.00 effectively realizes the spread; this pattern can reflect routine exercise/sell activity or a 10b5-1 plan (not a direct endorsement of the stock). The 10b5-1 plan noted in the filing (F1) indicates at least some trades may have been preplanned. Derivative-line entries at $0.00 likely reflect conversion/settlement mechanics — see footnote F3 for graded vesting.

Insider Transaction Report

Form 4
Period: 2026-07-06
Taffe Norman P
President Generac Home
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-07-06$256.00/sh200$51,20015,908 total
  • Sale

    Common Stock

    [F1][F2]
    2026-07-06$256.00/sh100$25,60015,808 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-07-06$119.54/sh+150$17,93115,958 total
  • Sale

    Common Stock

    [F1]
    2026-07-06$256.00/sh150$38,40015,808 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-07-06$119.54/sh+100$11,95415,908 total
  • Sale

    Common Stock

    [F1][F2]
    2026-07-06$256.00/sh100$25,60015,808 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3]
    2026-07-061502,720 total
    Exercise: $119.54Exp: 2033-03-01Common Stock (150 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3]
    2026-07-061002,620 total
    Exercise: $119.54Exp: 2033-03-01Common Stock (100 underlying)
Footnotes (3)
  • [F1]Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
  • [F2]Multiple lots for the same price for this order have been combined.
  • [F3]Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.
Signature
/s/ Raj Kanuru, Attorney in Fact|2026-07-07

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4